Rizatriptan n10-oxide(CAS: 260435-42-5)

Rizatriptan n10-oxide has a crystalline form with a melting point around 198-200°C. Its molecular weight is approximately 389.47 g/mol. It is slightly soluble in water and ethanol. Chemically, it is relatively stable but can react with strong acids and bases. It is a white or off-white solid with poor solubility in common organic solvents.

Rizatriptan n10-oxide is synthesized by the oxidation of rizatriptan using a suitable oxidizing agent like potassium permanganate in the presence of a suitable solvent like dimethylformamide (DMF). The reaction is carried out under controlled conditions to ensure high selectivity and yield. The product's purity is improved through recrystallization, and it is typically obtained as a white solid.

Rizatriptan n10-oxide is primarily used in the pharmaceutical industry. It is a key intermediate in the synthesis of rizatriptan, a drug used to treat migraine headaches. Additionally, it may have applications in polymer science and materials science, particularly in the development of new drug delivery systems and sensors.

When handling Rizatriptan n10-oxide, it is essential to wear appropriate personal protective equipment (PPE) such as gloves, safety glasses, and a lab coat. Ensure to work in a well-ventilated area or a fume hood to minimize inhalation risks. Spills should be cleaned up immediately using appropriate absorbent materials. Always consult the safety data sheet (SDS) for detailed handling instructions and emergency procedures.